196 related articles for article (PubMed ID: 2420773)
1. Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy.
Tahara E; Sumiyoshi H; Hata J; Yasui W; Taniyama K; Hayashi T; Nagae S; Sakamoto S
Jpn J Cancer Res; 1986 Feb; 77(2):145-52. PubMed ID: 2420773
[TBL] [Abstract][Full Text] [Related]
2. Expression of epidermal growth factor receptor in human gastric and colonic carcinomas.
Yasui W; Sumiyoshi H; Hata J; Kameda T; Ochiai A; Ito H; Tahara E
Cancer Res; 1988 Jan; 48(1):137-41. PubMed ID: 2446740
[TBL] [Abstract][Full Text] [Related]
3. [Human epidermal growth factor (h-EGF) in gastric carcinomas].
Fushida S; Yonemura Y; Sugiyama K; Matsumoto H; Kamata T; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1988 Dec; 89(12):1965-8. PubMed ID: 3265984
[TBL] [Abstract][Full Text] [Related]
4. Mucosal thickening adjacent to gastric malignancy: association with epidermal growth factor.
Lee EY; Wang TC; Clouse RE; DeSchryver-Kecskemeti K
Mod Pathol; 1989 Jul; 2(4):397-402. PubMed ID: 2788275
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptors in gastric adenocarcinoma: a retrospective immunohistochemical analysis.
Yokozaki H; Takekura N; Takanashi A; Tabuchi J; Haruta R; Tahara E
Virchows Arch A Pathol Anat Histopathol; 1988; 413(4):297-302. PubMed ID: 2845639
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and secretion of an hEGF-like immunoreactive factor by human gastric cancer cells (MKN-45).
Mori K; Ibaragi S; Kurobe M; Furukawa S; Hayashi K
Biochem Int; 1987 May; 14(5):779-85. PubMed ID: 3502641
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor-receptor expression correlates with tumor cell proliferation and prognosis in gastric cancer.
Jonjić N; Kovac K; Krasević M; Valković T; Ernjak N; Sasso F; Melato M
Anticancer Res; 1997; 17(5B):3883-8. PubMed ID: 9427797
[TBL] [Abstract][Full Text] [Related]
9. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
[TBL] [Abstract][Full Text] [Related]
10. [Monoclonal antibody NCC-ST-439 in gastric cancer tissue].
Kamata T; Yoneumura Y; Sugiyama K; Yamaguchi A; Miwa K; Miyazaki I
Nihon Geka Gakkai Zasshi; 1989 Feb; 90(2):222-7. PubMed ID: 2747606
[TBL] [Abstract][Full Text] [Related]
11. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.
Christensen ME
Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699
[TBL] [Abstract][Full Text] [Related]
12. [Oncogenes in human gastric carcinoma].
Tahara E
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2149-55. PubMed ID: 2544146
[TBL] [Abstract][Full Text] [Related]
13. Impact of epidermal growth factor (EGF) radioreceptor analysis on long-term survival of gastric cancer patients.
Kopp R; Ruge M; Rothbauer E; Cramer C; Kraemling HJ; Wiebeck B; Schildberg FW; Pfeiffer A
Anticancer Res; 2002; 22(2B):1161-7. PubMed ID: 12168918
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of epidermal growth factor and epidermal growth factor receptor in gastric carcinoma.
Sugiyama K; Yonemura Y; Miyazaki I
Cancer; 1989 Apr; 63(8):1557-61. PubMed ID: 2647276
[TBL] [Abstract][Full Text] [Related]
15. A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for Scirrhous gastric cancer.
Nakamura K; Yashiro M; Matsuoka T; Tendo M; Shimizu T; Miwa A; Hirakawa K
Gastroenterology; 2006 Nov; 131(5):1530-41. PubMed ID: 17101326
[TBL] [Abstract][Full Text] [Related]
16. Human brain tumor-associated urinary high molecular weight transforming growth factor: a high molecular weight form of epidermal growth factor.
Stromberg K; Hudgins WR; Dorman LS; Henderson LE; Sowder RC; Sherrell BJ; Mount CD; Orth DN
Cancer Res; 1987 Feb; 47(4):1190-6. PubMed ID: 3026622
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical detection of c-myc oncogene product in human gastric carcinomas: expression in tumor cells and stromal cells.
Yamamoto T; Yasui W; Ochiai A; Ito H; Abe K; Yanaihara N; Tahara E
Jpn J Cancer Res; 1987 Nov; 78(11):1169-74. PubMed ID: 2447046
[TBL] [Abstract][Full Text] [Related]
18. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function.
Zolfaghari A; Djakiew D
Prostate; 1996 Apr; 28(4):232-8. PubMed ID: 8602399
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.
Lazăr D; Tăban S; Raica M; Sporea I; Cornianu M; Goldiş A; Vernic C
Rom J Morphol Embryol; 2008; 49(2):137-48. PubMed ID: 18516318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
